Esketamine
Spravato Without an Oral Antidepressant: What Monotherapy Means for Patients
October 29, 2026
Your First Spravato Appointment: Planning for Monitoring, Recovery, and the Ride Home
October 29, 2026
Esketamine, Ketamine, and Compounded Products: How to Read the Differences
October 29, 2026
FDA Expands Spravato Label to Allow Standalone Treatment for Resistant Depression
October 28, 2026
2025 Randomized Trial Tests Esketamine as a Standalone Depression Treatment
October 28, 2026
MDMA Found Effective for Treatment of PTSD in Phase-3 Trial Results
March 25, 2022
Popular Soap Company–Dr. Bronner’s– Plans To Explore The Psychedelic Space
March 22, 2022
Psychedelic and Plant Medicine Decriminalization Efforts Spread to the Midwest.
March 15, 2022
What There is to Know About Ketamine vs. Electroconvulsive Therapy (ECT)
March 3, 2022
Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare
February 24, 2022
A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”
February 22, 2022
Aggregate Study on the Efficacy of Ketamine to Treat Depression Shows Promising Results.
February 17, 2022
Page 1 of 2Older →